MAPT and frontotemporal dementia: The “Other TDP-43” group, serving primarily to rule out participants from the LATE-NC group, was a combination of FTLD-tau pathologies (CBD and CTE), acute or chronic TBI as assessed at autopsy, and participants with FTD-related or ADAD-related mutations.